asensus aps is a computer software company based out of 22a vallensbækvej, brondby, capital region of denmark, denmark.
Company profile
Ticker
ASXC
Exchange
Website
CEO
Todd Pope
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CELLULAR TECHNICAL SERVICES CO INC, SafeStitch Medical, Inc., TRANSENTERIX INC., TRANSENTERIX, INC.
SEC CIK
Corporate docs
Subsidiaries
Asensus Surgical US, Inc. • Asensus International, Inc. • Asensus Surgical Italia, S.r.l. • Asensus Surgical Europe • Asensus Surgical Netherlands B.V. • Asensus Surgical Israel Ltd • Asensus Surgical Canada, Inc. • Asensus Surgical Japan K.K. • Asensus Taiwan Ltd. ...
IRS number
112962080
ASXC stock data
Latest filings (excl ownership)
8-K
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG
3 Apr 24
8-K
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023
25 Mar 24
10-K
2023 FY
Annual report
21 Mar 24
8-K
Asensus Surgical Provides Preliminary 2023 Year-End Corporate Update
8 Jan 24
8-K
Asensus Surgical Completes In Vivo Surgeon Lab for LUNA Surgical Robotic System
4 Jan 24
8-K
Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2023
16 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Other Events
19 Sep 23
8-K
Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2023
11 Aug 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
Transcripts
ASXC
Earnings call transcript
2023 Q4
21 Mar 24
ASXC
Earnings call transcript
2023 Q3
14 Nov 23
ASXC
Earnings call transcript
2023 Q2
10 Aug 23
ASXC
Earnings call transcript
2023 Q2
1 Aug 23
ASXC
Earnings call transcript
2023 Q1
11 May 23
ASXC
Earnings call transcript
2022 Q3
11 Nov 22
ASXC
Earnings call transcript
2022 Q2
9 Aug 22
ASXC
Earnings call transcript
2022 Q1
5 May 22
ASXC
Earnings call transcript
2021 Q4
1 Mar 22
ASXC
Earnings call transcript
2021 Q3
3 Nov 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 23.28 mm | 23.28 mm | 23.28 mm | 23.28 mm | 23.28 mm | 23.28 mm |
Cash burn (monthly) | (no burn) | (no burn) | 6.75 mm | 6.80 mm | 5.02 mm | 5.36 mm |
Cash used (since last report) | n/a | n/a | 44.74 mm | 45.05 mm | 33.24 mm | 35.51 mm |
Cash remaining | n/a | n/a | -21.46 mm | -21.77 mm | -9.95 mm | -12.22 mm |
Runway (months of cash) | n/a | n/a | -3.2 | -3.2 | -2.0 | -2.3 |
Institutional ownership, Q3 2023
9.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 65 |
Opened positions | 5 |
Closed positions | 17 |
Increased positions | 16 |
Reduced positions | 12 |
13F shares | Current |
---|---|
Total value | 6.74 bn |
Total shares | 25.41 mm |
Total puts | 120.50 k |
Total calls | 303.90 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 11.39 mm | $3.08 bn |
BLK Blackrock | 3.47 mm | $936.13 mm |
Geode Capital Management | 2.28 mm | $616.34 mm |
Masters Capital Management | 2.00 mm | $540.00 mm |
Millennium Management | 1.24 mm | $334.10 mm |
STT State Street | 952.93 k | $257.29 mm |
UBS UBS Group AG - Registered Shares | 669.33 k | $180.72 mm |
AlphaCentric Advisors | 500.00 k | $135.00 mm |
NTRS Northern Trust | 438.13 k | $118.29 mm |
Advisor | 283.17 k | $76.46 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Feb 24 | Fernando Anthony C. J. | RSU Common Stock | Grant | Acquire A | No | No | 0 | 1,238,700 | 0.00 | 1,238,700 |
6 Feb 24 | Fernando Anthony C. J. | RSU Common Stock | Grant | Acquire A | No | No | 0 | 2,477,400 | 0.00 | 2,477,400 |
6 Feb 24 | Fernando Anthony C. J. | Stock Options Common Stock | Grant | Acquire A | No | No | 0.26 | 1,488,100 | 386.91 k | 1,488,100 |
6 Feb 24 | Shameze Rampertab | RSU Common Stock | Grant | Acquire A | No | No | 0 | 330,300 | 0.00 | 330,300 |
6 Feb 24 | Shameze Rampertab | RSU Common Stock | Grant | Acquire A | No | No | 0 | 660,600 | 0.00 | 660,600 |
6 Feb 24 | Shameze Rampertab | Stock Options Common Stock | Grant | Acquire A | No | No | 0.26 | 396,800 | 103.17 k | 396,800 |
4 Feb 24 | Fernando Anthony C. J. | Common Stock | Payment of exercise | Dispose F | No | No | 0.27 | 484,572 | 130.83 k | 2,046,593 |
4 Feb 24 | Fernando Anthony C. J. | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,042,772 | 0.00 | 2,531,165 |
4 Feb 24 | Fernando Anthony C. J. | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 125,000 | 0.00 | 250,000 |
4 Feb 24 | Fernando Anthony C. J. | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 125,000 | 0.00 | 250,000 |
News
Wayfair To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Thursday
4 Apr 24
HC Wainwright & Co. Downgrades Asensus Surgical to Neutral, Lowers Price Target to $0.35
4 Apr 24
HC Wainwright & Co. Maintains Buy on Asensus Surgical, Maintains $2 Price Target
22 Mar 24
Recap: Asensus Surgical Q4 Earnings
21 Mar 24
Asensus Surgical Q4 EPS $(0.07) Beats $(0.08) Estimate, Sales $5.43M Beat $5.30M Estimate
21 Mar 24
Press releases
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG
3 Apr 24
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023
21 Mar 24
Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024
15 Mar 24
Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
28 Feb 24
Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals
27 Feb 24